Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Si Shi

Showing results (291-300 of 315) with videos related to

Pageof 32
Sort By:
Cell Reports. Medicine|October 18, 2023
Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-responseRong Tang, Jin Xu, Wei Wang, et al.
Cancer Letters|February 9, 2016
ALDOA functions as an oncogene in the highly metastatic pancreatic cancerShunrong Ji, Bo Zhang, Jiang Liu, et al.
Surgical Endoscopy|June 17, 2026
Multi-label dynamic diagnosis of pancreatic diseases using AI-enhanced endoscopic ultrasound: a multi-cohort real-world studyKe Chen, Kai Zhang, Chunbing Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2016
FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic CancerShunrong Ji, Yi Qin, Chen Liang, et al.
International Journal of Biological Macromolecules|June 9, 2025
Extracellular GMFB activates the non-canonical FAS-FAF1 pathway to induce lysosomal dysfunction in early diabetic retinopathyCaiying Liu, Furong Gao, Lilin Zhu, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2024
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancerPanpan Zhang, Zhendong Chen, Si Shi, et al.
Nature Communications|May 28, 2026
Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancerRong Tang, Yangyi Li, Cong Zhou, et al.
World Neurosurgery|November 29, 2016
Spontaneous Spinal Epidural Hematoma: A Study of 55 Cases Focused on the Etiology and Treatment StrategyJia-Xing Yu, Jiang Liu, Chuan He, et al.
Cell Reports. Medicine|September 20, 2025
A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancerSi Shi, Jian Zhang, Rujiao Liu, et al.
Biomaterials|December 24, 2021
Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancerWenxi Zhou, Xinli Chen, Yu Zhou, et al.
Pageof 32

Showing results (291-300 of 315) with videos related to

Sort By:
Pageof 32
Cell Reports. Medicine|October 18, 2023
Targeting neoadjuvant chemotherapy-induced metabolic reprogramming in pancreatic cancer promotes anti-tumor immunity and chemo-responseRong Tang, Jin Xu, Wei Wang, et al.
Cancer Letters|February 9, 2016
ALDOA functions as an oncogene in the highly metastatic pancreatic cancerShunrong Ji, Bo Zhang, Jiang Liu, et al.
Surgical Endoscopy|June 17, 2026
Multi-label dynamic diagnosis of pancreatic diseases using AI-enhanced endoscopic ultrasound: a multi-cohort real-world studyKe Chen, Kai Zhang, Chunbing Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2016
FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic CancerShunrong Ji, Yi Qin, Chen Liang, et al.
International Journal of Biological Macromolecules|June 9, 2025
Extracellular GMFB activates the non-canonical FAS-FAF1 pathway to induce lysosomal dysfunction in early diabetic retinopathyCaiying Liu, Furong Gao, Lilin Zhu, et al.
Cancer Immunology, Immunotherapy : CII|May 7, 2024
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancerPanpan Zhang, Zhendong Chen, Si Shi, et al.
Nature Communications|May 28, 2026
Metabolic characterization of the tumor microenvironment orchestrates therapeutic strategies and clinical outcomes in pancreatic cancerRong Tang, Yangyi Li, Cong Zhou, et al.
World Neurosurgery|November 29, 2016
Spontaneous Spinal Epidural Hematoma: A Study of 55 Cases Focused on the Etiology and Treatment StrategyJia-Xing Yu, Jiang Liu, Chuan He, et al.
Cell Reports. Medicine|September 20, 2025
A phase 1 trial of APG-1387, an IAP antagonist, with nab-paclitaxel and gemcitabine in patients with refractory metastatic pancreatic cancerSi Shi, Jian Zhang, Rujiao Liu, et al.
Biomaterials|December 24, 2021
Exosomes derived from immunogenically dying tumor cells as a versatile tool for vaccination against pancreatic cancerWenxi Zhou, Xinli Chen, Yu Zhou, et al.
Pageof 32